Lahore: LIVEN Pharma Limited has announced a forthcoming meeting of its Board of Directors scheduled for October 31, 2026, at noon. The meeting, to be held via Zoom, will focus on reviewing the company's quarterly accounts for the period ending September 30, 2026. The board aims to deliberate on declaring any entitlements based on the quarterly financial performance.

In compliance with the Pakistan Stock Exchange (PSX) regulations, LIVEN Pharma Limited has instituted a Closed Period from October 24, 2026, to October 31, 2026. During this time frame, as per regulation 5.6.1(d), no director, CEO, or executive is permitted to engage in any transactions involving the company’s shares. This is to ensure adherence to governance standards and to prevent any potential conflicts of interest.

According to information available from the Pakistan Stock Exchange (PSX), the implementation of such Closed Periods is a standard regulatory practice intended to uphold market integrity. This period restricts trading activities by individuals with access to potentially sensitive and undisclosed financial information.

The pharmaceuticals market category continues to be a significant focus of the Pakistan Stock Exchange, with companies like LIVEN Pharma Limited adhering to the rigorous standards set by the exchange. The upcoming board meeting is part of the company's regular governance activities, ensuring transparency and accountability in its financial disclosures.